“airea - The Airport Region in Central Germany” is one of the top national and global addresses for the bio-tech and pharmaceutical industry. With efficient manufacturers, bio-logistics specialists and a broad-based and highly innovative research landscape, there are ideal development conditions and connecting factors for companies and investors in the sector. These will be presented by the three partners of “airea”, Mitteldeutsche Flughafen AG (MFAG), Wirtschaftsförderung Sachsen GmbH (WFS) and Investitions- und Marketinggesellschaft Sachsen-Anhalt mbH (IMG) at the Swiss Biotech Day event.
“The region scores with efficient production and supplier structures and a network of professional and technical expertise that has evolved over many years. Due to the complexity of the products and processes this is essential for the industry and underlines its attractiveness for companies and investors. We want to present this to a wider audience at Swiss Biotech Day,” explains WFS Managing Director Thomas Horn.
As a region, “airea” covers the entire value chain: from research and development via production and marketing to logistics and service. The airport offers an international distribution network towards Europe, Africa and the Middle East that is specifically aligned to the production of vaccines and medicine. In total, more than 70 cargo airlines fly to the airport and serve a route network that includes more than 270 destinations worldwide.
Götz Ahmelmann, CEO of MFAG: "Handling temperature- and time-critical cargo is already an everyday business for us, which we want to expand and solidify. We want to become even more visible to investors and thus generate even more positive impulses for the marketing of our space."
In addition to excellent connections to the trans-European rail and motorway network, the region is characterized by a qualified workforce and a high level of space and investment potential. In the Leipzig/Halle airport area, attractive spaces are available for a variety of businesses – e.g. directly at the airport or near Halle (Saale), Eilenburg, Zeitz and Wermsdorf
Dr. Robert Franke, IMG Managing Director, adds: “Newly settled companies in the biotech industry sector will find the best location conditions for investment and growth here and can optimally deliver time-critical freight from the heart of Germany to its destination. Whether it be international corporations, innovative medium-sized companies or young start-ups - the companies particularly appreciate the potential of interdisciplinary and cross-sectoral cooperation.”
A further goal of the presentation in Basel is to invite interested representatives from the biotech industry with an eye for investment to come and see for themselves the advantages of the location. As part of a delegation trip, the Trade and Invest Cooperations from Saxony-Anhalt and Saxony, together with German Trade and Invest (GTAI), are inviting interested entrepreneurs from Austria and Switzerland to join them in Central Germany from July 03-06, 2023.
You can find further information here.